UnitedHealth Group Incorporated (NYSE:UNH) Stake Lessened by YANKCOM Partnership

YANKCOM Partnership lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 75.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 534 shares of the healthcare conglomerate's stock after selling 1,631 shares during the quarter. YANKCOM Partnership's holdings in UnitedHealth Group were worth $280,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Capital Advisors Inc. OK increased its holdings in shares of UnitedHealth Group by 1.5% during the 1st quarter. Capital Advisors Inc. OK now owns 77,077 shares of the healthcare conglomerate's stock worth $40,369,000 after buying an additional 1,103 shares during the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of UnitedHealth Group by 4.7% during the 1st quarter. Envestnet Asset Management Inc. now owns 2,239,866 shares of the healthcare conglomerate's stock worth $1,173,130,000 after buying an additional 99,979 shares during the last quarter. Drake & Associates LLC increased its holdings in UnitedHealth Group by 22.5% in the 1st quarter. Drake & Associates LLC now owns 1,110 shares of the healthcare conglomerate's stock valued at $581,000 after purchasing an additional 204 shares in the last quarter. Financiere des Professionnels Fonds d investissement inc. increased its holdings in UnitedHealth Group by 10.6% in the 1st quarter. Financiere des Professionnels Fonds d investissement inc. now owns 811 shares of the healthcare conglomerate's stock valued at $425,000 after purchasing an additional 78 shares in the last quarter. Finally, Traveka Wealth LLC increased its holdings in UnitedHealth Group by 4.2% in the 1st quarter. Traveka Wealth LLC now owns 1,050 shares of the healthcare conglomerate's stock valued at $550,000 after purchasing an additional 42 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on UNH. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Wolfe Research lowered their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Piper Sandler lowered their target price on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research note on Tuesday, June 3rd. Bank of America downgraded UnitedHealth Group from a "buy" rating to a "neutral" rating and lowered their target price for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, Robert W. Baird downgraded UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price for the company. in a research note on Wednesday, June 11th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus target price of $415.57.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded up $3.84 during trading hours on Tuesday, hitting $307.55. The stock had a trading volume of 2,489,077 shares, compared to its average volume of 7,546,935. The stock's fifty day simple moving average is $322.66 and its 200 day simple moving average is $445.65. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The firm has a market capitalization of $278.99 billion, a price-to-earnings ratio of 12.88, a PEG ratio of 1.48 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.87%. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Insider Activity

In related news, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was acquired at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the purchase, the chief financial officer directly owned 203,796 shares in the company, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kristen Gil acquired 3,700 shares of UnitedHealth Group stock in a transaction dated Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director owned 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock worth $31,607,768 in the last quarter. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.